Southbound Capital Drives Hong Kong Stock Accumulation as Foreign Funds Stage Major Comeback from Mid-July
0xBroomberg
Since July, southbound capital has net-bought HK$75.1 billion into Hong Kong stocks while foreign funds have poured back in — over HK$60 billion since July 16 — shifting from passive rebalancing to active accumulation. The two camps' sector bets are near-perfect mirror images, reshaping how Hong Kong equities get priced.
Who is buying Hong Kong stocks — and how much?
As of August 5, southbound capital (mainland China → HK) led with HK$75.1 billion in net inflows. International intermediaries added HK$6.9 billion, while Chinese-broker and local-HK channels net-sold HK$30.9 billion and HK$8.1 billion respectively.
Foreign funds have net-bought over HK$60 billion since July 16, gradually moving from passive position-rebuilding to active and passive money buying in sync.
This means → Hong Kong's market is shifting from "mainland money holding it up alone" to "dual-source pricing," and that thicker capital base matters.
Why are mainland and foreign money buying almost exactly opposite sectors?
Southbound capital loaded up on tech, materials, and pharma while cutting financials and industrials. Foreign funds did the reverse — buying financials, consumer discretionary, and industrials, selling tech, materials, and pharma.
At the sub-sector level the mirror is sharper: mainland money bought software, non-ferrous metals, and semis; foreign money bought banks, insurance, and industrial engineering.
This reflects two completely different theses: mainland capital is betting on China's tech-self-reliance narrative; foreign capital wants valuation repair and predictable cash flow.
How did mainland and foreign money "relay" each other in internet stocks?
Early-to-mid July: mainland in, foreign out. Late July: mainland pulling back, foreign surging in. Since early August: both buying together — and the rally's slope steepened.
In plain terms = mainland money entered first and lifted prices; foreign money took the baton and pushed them higher. Now both sides are finally moving the same way.
Whether this convergence holds is the key variable for the next leg of Hong Kong internet stocks.
Biotech and high-dividend names — the same rotation pattern?
Innovative pharma: mainland capital was the main buyer in July while foreign funds took profits. Since late July, mainland flows turned negative and foreign money stepped in — another textbook relay.
High-dividend stocks: mainland money bought aggressively in early-to-mid July, then sold after global risk appetite rose in late July. Foreign funds have been net-buying steadily since mid-July.
This means → the foreign comeback is not a single-theme bet. It is a two-track play — internet plus high-dividend — balancing offence and defence.
At the single-stock level — where is the disagreement sharpest?
Over the past 20 days, southbound money mainly bought Zhipu, NetEase, Alibaba, Kuaishou, Tianshu Zhixin, GigaDevice, China Hongqiao, Zijin Mining, and Insilico Medicine, while selling Kingboard Laminates, Meituan, Tencent, Xiaomi, SMIC, YOFC, Sinopec, China Life, and ICBC.
Foreign funds mainly bought Tencent, Meituan, Xiaomi, CCB, ICBC, Zhongji Innolight (with Goldman Sachs and JPMorgan disclosing significant stake increases), and BYD, while selling Zhipu, MiniMax, NetEase, Alibaba, Biren Technology, China Hongqiao, and Zijin Mining.
Put simply = mainland money sells Tencent and Meituan while foreign money buys them; mainland money buys Zhipu and non-ferrous names while foreign money sells them — the same stock, opposite trades, a strikingly sharp divergence.
Content is for reference only, not financial advice.